Maintaining physical activity for cancer survivors after exercise programs

An Adaptive Physical Activity Maintenance Intervention

Not applicable Interventional Colorado State University · NCT06359210

This study is testing a new way to help cancer survivors keep up their exercise habits after finishing a community exercise program.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment105 (estimated)
Ages18 Years and up
SexAll
SponsorColorado State University Academic / other
Drugs / interventionschemotherapy, radiation
Locations3 sites (Aurora, Colorado and 2 other locations)
Trial IDNCT06359210 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to develop and test an adaptive intervention to help cancer survivors maintain physical activity after completing a community-based exercise program. The study will assess the feasibility and acceptability of the intervention through surveys, focus groups, and interviews, while also evaluating the effectiveness of the intervention in helping participants meet exercise guidelines six months post-program. By utilizing a socio-ecological approach and theoretical frameworks, the researchers hope to enhance long-term physical activity maintenance among cancer survivors.

Who should consider this trial

Good fit: Ideal candidates for this study are cancer survivors aged 18 and older who have completed their primary or adjuvant treatment within the last five years and are enrolled in a community-based exercise program.

Not a fit: Patients who are already engaging in high levels of physical activity or have contraindications for exercise may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the long-term health and quality of life for cancer survivors by promoting sustained physical activity.

How similar studies have performed: While there is emerging evidence supporting the effectiveness of exercise interventions for cancer survivors, this specific approach to maintaining physical activity post-intervention is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥18 years old,
* Able to speak/read English,
* Diagnosed with any type of cancer,
* Completed primary or adjuvant treatment (i.e., chemotherapy, radiation therapy, surgery) within the previous five years, with no planned treatment within the next nine months. This does not include long-term or chronic therapies such as anti-hormone or targeted therapies (e.g., aromatase inhibitor, androgen deprivation therapy),
* Participant is registered/enrolled to participate in one of three community-based exercise programs.

Exclusion Criteria:

* Existing participation in ≥90 minutes per week of at least moderate intensity aerobic exercise AND two or more days per week of resistance exercise or known contraindications for exercise.
* Known contraindications for non-medically supervised moderate or greater intensity exercise (e.g., uncontrolled hypertension, inability to walk without an assistive device)
* Current or planned participation in another exercise oncology program (not one of the three community partner exercise programs), or previous participation in another or one of the three community partner exercise programs in the past 12-months.

Where this trial is running

Aurora, Colorado and 2 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Exercise OncologyPhysical Activity BehaviorBehavior Change Interventionsexercise oncologyphysical activitybehavior changeadaptive interventioncancer survivors
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.